But an association with improved overall survival failed to reach statistical significance ...

“Oxybutynin demonstrated clear and clinically meaningful improvements in both hot flash frequency and quality of life for men undergoing hormone therapy for prostate cancer,” said lead researcher Dr.

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

An electronic health record-integrated AI agent developed to improve patient education on prostate cancer with personalized ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

K36 Therapeutics, Inc. ("K36"), a privately held clinical-stage biotechnology company developing novel targeted therapies for ...

Metastasis-directed therapy (MDT) significantly improved outcomes in patients with oligometastatic prostate cancer, according ...

Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. Researchers at the Norwegian ...

Radiation therapy is often described in clinical terms, but rarely through the eyes of the person lying on the treatment ...

Metastasis-directed therapy (MDT) delivered via stereotactic body radiotherapy has gained substantial attention over the past decade. Landmark trials such as STOMP1 and ORIOLE2 fundamentally shifted ...

As we gear up to observe World Cancer Day 2026 under the theme 'United by Unique', let's take a look at the stages of ...